Gelteq

Gelteq

Pharmaceuticals
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.

$5.7M

Market Cap • 10/1/2026

2018

(8 years)

Founded

2024

(2 years ago)

IPO

NASDAQ

Listing Exchange

Flag of Australia

Australia

Country

Valuation

P/B

0,6

P/S

—

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

0,9

EPS

—

Market Cap

Market Cap

5,7M

EV

9,1M

EV/Revenue

0

EV/EBITDA

-2,8

EV/EBIT

-2,2

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-14,5%

Total Yield

-14,5%

Payout

0%

Retained Earnings

-14,6M

Profitability

Gross Margin

—

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

0%

Capex/Revenue

0%

Capex/D&A

0%

Capex/OCF

0%

SBC/OCF

—

% PPE

0,1%

% Goodwill

0%

ROE

—

ROIC

—

Leverage

N.D./EBITDA

—

Debt/Equity

0%

Current Ratio

0,1

Quick Ratio

0,1

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium